查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2001149

急性期側腦室引流市場：依產品類型、技術、引流方法、病患年齡層、應用、最終用戶和通路分類－2026-2032年全球市場預測

Acute External Ventricular Drain Market by Product Type, Technology, Drainage Type, Patient Age Group, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，急性體外腦室引流市場價值將達到 2.9393 億美元，到 2026 年將成長至 3.3064 億美元，到 2032 年將達到 5.9444 億美元，年複合成長率為 10.58%。

主要市場統計數據
基準年 2025 2.9393億美元
預計年份：2026年 3.3064億美元
預測年份 2032 5.9444億美元
複合年成長率 (%) 10.58%

簡要概述了影響現代神經重症監護環境中急性側腦室引流使用的不斷變化的臨床、監管和運營環境。

急性側腦室引流（EVD）系統仍然是神經重症監護的基石，在腦脊髓液排放、顱內壓監測和急診神經外科手術中發揮著至關重要的作用。近期的臨床實踐強調對水腦症、蜘蛛網膜下腔出血、創傷性腦損傷和複雜性顱內高壓患者進行基於通訊協定的快速介入。因此，臨床醫生和醫療系統需要在臨床療效、感染預防、易用性和工作流程效率之間取得平衡。這些優先事項影響急症護理機構的採購考量和採購流程。

感染控制重點、分散式照護路徑和採購政策如何以總體擁有成本 (TCO) 為中心，從而改變醫療設備的設計和商業化策略？

近年來，醫院和專科醫療中心用於急性期的體外腦室引流管的設計、供應和使用發生了變革性變化。臨床上，最大限度地減少感染和提高監測精度變得日益重要，這推動了封閉式系統技術和整合壓力感測功能的應用。同時，在醫療服務模式中，某些神經外科手術向門診手術中心和專科診所的分散化，正在改變需求模式並影響庫存策略。

本報告預測了美國關稅結構調整對商業性和供應鏈的影響，以及製造商和醫療保健系統在 2025 年應考慮的策略選擇。

美國計劃於2025年調整關稅政策，將對醫療設備（包括組件和組裝急性護理用外腦室引流管）的採購和整個供應鏈產生重大影響。關稅調整將影響進口原料和成品的到貨成本，進而可能影響籌資策略、與供應商的談判以及國內外工廠之間的產能分配。因此，採購團隊和製造商必須評估供應商合約、避險策略以及最終用戶可能面臨的價格上漲風險，同時也要考慮到醫院的預算限制。

一項基於細分市場的綜合評估，揭示了臨床適應症、醫療保健環境、產品架構和分銷管道如何全面影響醫療器材的設計和商業性部署路徑。

細分分析揭示了每種臨床應用、最終用戶、產品類型、技術、引流方法、患者群體和分銷管道的不同促進因素和採用路徑。依應用領域分類，醫療設備設計和臨床工作流程直接滿足諸如水腦症管理、顱內壓監測、蜘蛛網膜下腔出血治療和創傷性腦損傷管理等需求，每種適應症對監測精度、導管耐用性和感染控制都有獨特的要求。就最終用戶而言，門診手術中心、醫院和專科診所在手術量、消毒能力和採購權限方面的差異，影響預組裝一次性套件與基於集中式再處理系統的吸引力比較。

全球神經重症監護市場趨勢、監管義務、區域趨勢和醫療保健系統特徵決定了商業策略。

區域趨勢影響著美洲、歐洲、中東和非洲以及亞太地區的部署模式、監管預期和競爭程度，每個地區都面臨獨特的機會和挑戰。在美洲，先進的神經重症監護能力、集中的三級神經病學中心以及整合的醫院採購框架正在推動功能豐富的封閉式系統和先進的一次性耗材包的普及，而私人和公共保險公司的發展趨勢則影響著部署時間和合約結構。對過渡期照護模式和打包支付的重視，促使醫療系統優先選擇那些能夠降低感染率和縮短住院時間的醫療設備。

競爭格局凸顯了規模、臨床證據和服務整合如何決定供應商差異化和市場定位。

急性側腦室引流領域的競爭動態由成熟的醫療技術公司、專業的神經外科醫療設備製造商和靈活的利基創新者組成。大型製造商利用其規模、全球分銷網路和廣泛的臨床產品組合來獲得醫院契約，並提供包括培訓、上市後監測和服務協議在內的複雜價值提案。同時，小規模的專業公司正在推動導管設計、封閉式系統技術和整合監測功能的創新，他們通常與臨床中心合作，以檢驗產品性能並加速臨床醫生採用這些技術。

製造商和醫療保健系統在神經重症監護領域提高臨床療效、供應鏈韌性和差異化商業性可行性的具體策略重點。

產業領導者應優先考慮在保障臨床療效的同時，簡化供應鏈和商業性執行流程。首先，應投資於臨床研究和真實世界數據（REW）項目，量化感染率、ICU住院時間和器械相關併發症的降低情況，從而為採購談判和報銷方案的調整提供支持。其次，應最佳化產品系列，涵蓋一次性高級套裝和可重複使用系統，使醫療機構能夠選擇符合自身消毒能力和成本控制目標的解決方案。在最佳化產品的同時，也應透過雙重採購、關鍵零件的近岸外包以及針對關稅導致的成本變化製定明確的緊急時應對計畫，來增強供應鏈的韌性。

採用嚴謹的混合方法，結合醫療保健專業人員的見解、監管審查和情境建模，確保對醫療設備、臨床實務和供應鏈的趨勢進行全面、檢驗的分析。

本執行摘要的調查方法融合了定性和定量方法，以確保證據基礎的穩健性和解讀的平衡性。主要資料來源包括對臨床負責人、採購負責人和工程團隊的結構化訪談，並輔以典型臨床實務流程的觀察分析。次要資料來源則利用同儕審查的臨床文獻、監管文件、醫療設備標籤和製造商產品規格，以支持技術能力和安全性方面的論點。

整合臨床、營運和商業性需求，以確定哪種策略方法能夠帶來永續的實施和患者照護。

總之，體外腦室引流系統在急性護理中佔據著至關重要的地位，它融合了臨床需求、操作要求和商業性複雜性。儘管臨床上日益重視感染控制和監測準確性，導致許多醫療機構傾向於使用密封系統和精心配置的一次性耗材包，但在無菌基礎設施能夠實現經濟高效重複使用的環境中，可重複使用系統仍然具有重要的戰略意義。為了適應不斷變化的收費系統和區域採購趨勢，需要製定前瞻性的供應鏈和商業計劃，以維持供應的穩定性和獲利能力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：急性期側腦室引流市場：依產品類型分類

  • 免洗工具包
    • 高級套件
    • 標準套件
  • 可重複使用系統
    • 多配置系統
    • 單配置系統

第9章：急性期側腦室引流市場：依技術分類

  • 封閉式系統
  • 開放系統

第10章：急性期側腦室引流市場－依引流類型分類

  • 連續排水
  • 間歇性排水

第11章：依病患年齡層別分類的急性期側腦室引流市場

  • 成人版
  • 兒童

第12章：急性護理側腦室引流市場：依應用領域分類

  • 水腦症的治療
  • 顱內壓監測
  • 蜘蛛網膜下腔出血的治療
  • 創傷性腦損傷的治療

第13章：急性護理側腦室引流市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第14章：急性期側腦室引流市場：依通路分類

  • 銷售代理
    • 醫療設備批發商
    • 藥品批發商
  • 電子商務
    • 製造商網站
    • 第三方網站
  • 醫院供應商
    • 與醫院直接簽訂合約
    • 集團採購組織

第15章：急性期側腦室引流市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章：急性期側腦室引流市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章：急性護理側腦室引流市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國急性護理側腦室引流市場

第19章：中國急性照護側腦室引流市場。

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Argi Group GmbH
  • B. Braun Melsungen AG
  • Christoph Miethke GmbH & Co. KG
  • DePuy Synthes
  • Elektron Instruments LLP
  • Hanni Medizintechnik GmbH
  • Head Sense Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • LivaNova PLC
  • Medtronic plc
  • Moller Medical GmbH
  • Natus Medical Incorporated
  • Neurologic Ltd.
  • Raumedic AG
  • Sophysa SA
  • Spiegelberg GmbH & Co. KG
  • Stryker Corporation
Product Code: MRR-957C47F8FEC9

The Acute External Ventricular Drain Market was valued at USD 293.93 million in 2025 and is projected to grow to USD 330.64 million in 2026, with a CAGR of 10.58%, reaching USD 594.44 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 293.93 million
Estimated Year [2026] USD 330.64 million
Forecast Year [2032] USD 594.44 million
CAGR (%) 10.58%

A concise orientation to the evolving clinical, regulatory, and operational context shaping acute external ventricular drain use across modern neurocritical care settings

Acute external ventricular drain (EVD) systems remain a cornerstone of neurocritical care, playing a critical role in cerebrospinal fluid diversion, intracranial pressure monitoring, and emergency neurosurgery. Recent clinical practice has emphasized rapid, protocol-driven interventions for patients with hydrocephalus, subarachnoid hemorrhage, traumatic brain injury, and complex intracranial hypertension. Consequently, clinicians and healthcare systems are balancing the need for clinical efficacy with infection prevention, ease of use, and workflow efficiency. These priorities have shaped purchasing considerations and procurement pathways across acute care settings.

Technology developments and changing care pathways have begun to alter expectations of EVD devices, from single-use, prepackaged kits to more modular reusable systems designed for sustainable operational models. At the same time, regulatory scrutiny around device sterility, post-market surveillance, and clinical outcomes has intensified, prompting manufacturers to strengthen evidence packages. Taken together, these dynamics create a landscape in which clinical demand, hospital operational constraints, and regulatory imperatives converge to influence device design, distribution, and adoption.

How infection-control priorities, decentralized care pathways, and procurement focus on total cost of ownership are reshaping device design and commercialization strategies

The last several years have witnessed transformative shifts in how acute external ventricular drains are designed, supplied, and used within hospitals and specialty centers. Clinically, there is growing emphasis on minimizing infection and improving monitoring precision, which has driven adoption of closed-system technologies and integrated pressure-sensing capabilities. At the same time, healthcare delivery models are decentralizing certain neurosurgical procedures to ambulatory surgical centers and specialty clinics, altering demand patterns and influencing stocking strategies.

Moreover, procurement teams are increasingly focused on total cost of ownership, favoring disposable kits that reduce reprocessing burdens while also exploring reusable systems that can be optimized through robust sterilization protocols. Digital health integration and remote monitoring are beginning to appear in adjacent device ecosystems, and regulatory frameworks have tightened around traceability and adverse event reporting, prompting manufacturers to prioritize post-market data collection. These converging shifts are prompting incumbent suppliers and new entrants to reassess product roadmaps and commercial strategies to align with clinician preferences and institutional imperatives.

Anticipating the commercial and supply chain consequences of United States tariff realignment and the strategic choices manufacturers and health systems must weigh in 2025

United States tariff policy changes projected for 2025 introduce material considerations across the procurement and supply chain landscape for medical devices, including components and assembled acute external ventricular drains. Tariff adjustments affect the landed cost of imported materials and finished devices, which in turn can influence sourcing strategies, supplier negotiations, and the allocation of manufacturing capacity between domestic and offshore facilities. Procurement teams and manufacturers must therefore evaluate supplier contracts, hedging strategies, and potential price pass-through to end users while remaining mindful of hospital budget constraints.

In response, manufacturers may intensify efforts to localize production, qualify alternative suppliers, or redesign product kits to reduce reliance on tariff-impacted components. Hospitals and group purchasing organizations will likely increase scrutiny of contract terms and inventory practices, seeking greater transparency on cost drivers. Importantly, tariff-related cost pressures can also accelerate interest in disposable kits that simplify logistics, or conversely, renew focus on reusable systems where capital investment and local sterilization can mitigate import exposure. Navigating this environment requires coordinated scenario planning between commercial, regulatory, and supply chain teams to preserve margins while sustaining clinical availability.

A comprehensive segmentation-driven assessment revealing how clinical indications, care settings, product architectures, and distribution channels collectively influence device design and commercial pathways

Segmentation analysis reveals differentiated drivers and adoption pathways across clinical applications, end users, product typologies, technologies, drainage approaches, patient demographics, and distribution modalities. By application, device design and clinical workflows respond directly to needs in hydrocephalus management, intracranial pressure monitoring, subarachnoid hemorrhage treatment, and traumatic brain injury management, with each indication imposing unique requirements for monitoring fidelity, catheter durability, and infection control measures. Regarding end users, ambulatory surgical centers, hospitals, and specialty clinics vary in procedural volume, sterile processing capabilities, and purchasing authority, shaping the appeal of preassembled disposable kits versus systems intended for centralized reprocessing.

Product type segmentation highlights a tension between disposable kits and reusable systems. Disposable kits, which include advanced and standard configurations, appeal where single-use sterility and simplified procedural setup reduce infection risk and staff time, whereas reusable systems, available as multi-component and single-component formats, can be preferable where sterilization infrastructure and throughput support cost amortization. Technology segmentation separates closed systems from open systems; closed systems typically reduce contamination risk and support clinician preference in intensive care environments, while open systems retain relevance where simplicity and cost are paramount. Drainage type stratification into continuous versus intermittent approaches affects drainage hardware and monitoring cadence, and patient age segmentation into adult and pediatric populations drives design differences in catheter size, monitoring thresholds, and caregiver training. Finally, distribution channels encompass distributors, ecommerce, and hospital vendors; distributor categories include medical device and pharmaceutical distributors, ecommerce pathways traverse manufacturer websites and third-party platforms, and hospital vendors operate through direct hospital contracts and group purchasing organizations. Each distribution pathway requires tailored commercial engagement strategies, contractual constructs, and logistics planning to align product availability with clinical demand.

Regional dynamics and healthcare system nuances that determine adoption trajectories, regulatory obligations, and commercial strategies across global neurocritical care markets

Regional dynamics shape adoption patterns, regulatory expectations, and competitive intensity across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct opportunities and constraints. In the Americas, advanced neurocritical care capacity, concentration of tertiary neurological centers, and integrated hospital procurement frameworks favor adoption of feature-rich closed systems and advanced disposable kits, while private and public payor dynamics influence acquisition timing and contract structures. Transitional care models and emphasis on bundled payments prompt health systems to prioritize devices that demonstrate reductions in infection rates and length of stay.

Across Europe, Middle East & Africa, regulatory harmonization efforts and national reimbursement policies influence market entry and adoption. In Western Europe, stringent device regulations and high standards for clinical evidence drive manufacturers to invest in post-market studies and value demonstrations, whereas in parts of the Middle East and Africa, infrastructure variability creates pockets of demand for both cost-effective reusable systems and readily available disposable kits. In the Asia-Pacific region, rapidly expanding neurosurgical capacity, strong local manufacturing ecosystems, and evolving regulatory pathways create opportunities for both global suppliers and regional manufacturers. Price sensitivity in some markets coexists with rising demand for advanced solutions in urban tertiary centers, prompting manufacturers to offer differentiated product tiers and flexible commercial models tailored to regional needs.

Competitive landscape characterization highlighting how scale, clinical evidence, and service integration determine supplier differentiation and market positioning

Competitive dynamics in the acute external ventricular drain space are shaped by a mix of established medtech firms, specialized neurosurgical device companies, and agile niche innovators. Larger manufacturers leverage scale, global distribution networks, and broad clinical portfolios to secure hospital contracts and support complex value propositions that include training, post-market surveillance, and service agreements. Conversely, smaller specialized firms drive innovation around catheter design, closed-system technology, and integrated monitoring features, often partnering with clinical centers to validate performance and accelerate clinician acceptance.

Collaboration between original equipment manufacturers and contract manufacturers has deepened, enabling faster product iterations and cost optimization while also dispersing supply chain risk. Strategic differentiation increasingly relies on clinical evidence generation, infection mitigation features, and lifecycle service offerings rather than on price alone. In addition, channel strategies vary: some suppliers emphasize direct hospital contracts and group purchasing organization participation, while others exploit distributor networks and digital channels to expand reach. Ultimately, competitive positioning depends on the ability to align clinical claims with operational value and to demonstrate measurable improvements in patient outcomes and workflow efficiencies.

Actionable strategic priorities for manufacturers and health systems to fortify clinical outcomes, supply resilience, and differentiated commercial execution in neurocritical care

Industry leaders should prioritize actions that safeguard clinical performance while streamlining supply and commercial execution. First, invest in clinical studies and real-world evidence programs that quantify reductions in infection rates, ICU duration, and device-related complications to support procurement discussions and reimbursement alignment. Second, optimize product portfolios to cover both disposable advanced kits and reusable system options, allowing institutions to select solutions that align with their sterilization capabilities and cost-management objectives. Parallel to product optimization, strengthen supply chain resilience through dual sourcing, nearshoring critical components, and clear contingency planning for tariff-driven cost shifts.

Commercially, tailor engagement models by end user and region, offering flexible contract terms, training packages, and evidence-backed value propositions for ambulatory surgical centers, hospitals, and specialty clinics. Embrace digital channels and manufacturer-owned ecommerce to support rapid replenishment and to capture demand from decentralized care sites. Finally, collaborate with clinical leaders to co-develop protocols that simplify device setup and maintenance, thereby reducing variability in outcomes and enhancing the perceived value of premium device attributes.

A rigorous mixed-methods approach combining clinician insight, regulatory review, and scenario modeling to ensure comprehensive and validated analysis of device, clinical, and supply chain dynamics

The research methodology for this executive summary integrates qualitative and quantitative approaches to ensure a robust evidence base and balanced interpretation. Primary inputs include structured interviews with clinical leaders, procurement professionals, and engineering teams, complemented by observational analysis of procedural workflows in representative care settings. Secondary inputs draw on peer-reviewed clinical literature, regulatory documentation, device labeling, and manufacturer product specifications to substantiate technology capabilities and safety profiles.

Analytical techniques employed include comparative feature mapping across product typologies, scenario-based supply chain modeling to assess tariff impacts, and segmentation analysis to identify distinct demand clusters by application, end user, and distribution channel. Wherever possible, findings were cross-validated through clinician expert panels and technical reviews to ensure practical relevance. Limitations and data gaps were explicitly identified, with recommended follow-up research areas to deepen insight into long-term clinical outcomes and device lifecycle economics.

Synthesis of clinical, operational, and commercial imperatives that determines which strategic approaches will deliver sustained adoption and measurable patient-care improvements

In conclusion, acute external ventricular drain systems occupy a critical intersection of clinical necessity, operational imperatives, and commercial complexity. Clinical emphasis on infection control and monitoring precision is tilting preference toward closed systems and carefully configured disposable kits in many care settings, even as reusable systems retain strategic importance where sterilization infrastructure supports cost-effective reuse. Tariff changes and regional purchasing dynamics require proactive supply chain and commercial planning to sustain availability and preserve margin structures.

Manufacturers that pair strong clinical evidence with flexible product portfolios, resilient sourcing strategies, and targeted regional commercial approaches will be best positioned to meet evolving clinician and purchaser expectations. Health systems and procurement teams, by contrast, will benefit from clearer total cost of ownership analyses, tighter protocol alignment, and selective adoption of devices that demonstrably reduce complications and workflow burden. Continued collaboration between clinical stakeholders, manufacturers, and supply chain partners will be essential to translate innovation into measurable improvements in patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Acute External Ventricular Drain Market, by Product Type

  • 8.1. Disposable Kits
    • 8.1.1. Advanced Kits
    • 8.1.2. Standard Kits
  • 8.2. Reusable Systems
    • 8.2.1. Multi Component Systems
    • 8.2.2. Single Component Systems

9. Acute External Ventricular Drain Market, by Technology

  • 9.1. Closed Systems
  • 9.2. Open Systems

10. Acute External Ventricular Drain Market, by Drainage Type

  • 10.1. Continuous Drainage
  • 10.2. Intermittent Drainage

11. Acute External Ventricular Drain Market, by Patient Age Group

  • 11.1. Adult
  • 11.2. Pediatric

12. Acute External Ventricular Drain Market, by Application

  • 12.1. Hydrocephalus Management
  • 12.2. Intracranial Pressure Monitoring
  • 12.3. Subarachnoid Hemorrhage Treatment
  • 12.4. Traumatic Brain Injury Management

13. Acute External Ventricular Drain Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Hospitals
  • 13.3. Specialty Clinics

14. Acute External Ventricular Drain Market, by Distribution Channel

  • 14.1. Distributors
    • 14.1.1. Medical Device Distributors
    • 14.1.2. Pharmaceutical Distributors
  • 14.2. Ecommerce
    • 14.2.1. Manufacturer Websites
    • 14.2.2. Third Party Websites
  • 14.3. Hospital Vendors
    • 14.3.1. Direct Hospital Contracts
    • 14.3.2. Group Purchasing Organizations

15. Acute External Ventricular Drain Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Acute External Ventricular Drain Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Acute External Ventricular Drain Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Acute External Ventricular Drain Market

19. China Acute External Ventricular Drain Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Argi Group GmbH
  • 20.6. B. Braun Melsungen AG
  • 20.7. Christoph Miethke GmbH & Co. KG
  • 20.8. DePuy Synthes
  • 20.9. Elektron Instruments LLP
  • 20.10. Hanni Medizintechnik GmbH
  • 20.11. Head Sense Medical, Inc.
  • 20.12. Integra LifeSciences Holdings Corporation
  • 20.13. LivaNova PLC
  • 20.14. Medtronic plc
  • 20.15. Moller Medical GmbH
  • 20.16. Natus Medical Incorporated
  • 20.17. Neurologic Ltd.
  • 20.18. Raumedic AG
  • 20.19. Sophysa SA
  • 20.20. Spiegelberg GmbH & Co. KG
  • 20.21. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 217. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 220. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 221. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 224. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 228. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 229. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 256. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 259. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 260. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 263. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 266. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 267. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 268. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 269. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 272. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 273. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 276. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 278. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 279. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 280. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2032 (USD MILLION)
  • TABLE 281. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2032 (USD MILLION)
  • TABLE 282. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2032 (USD